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In the present study, a mesoporous phosphate-based glass (MPG) in the P2O5-CaO-Na2O 
system was synthesised, for the first time, using a combination of sol-gel chemistry and 
supramolecular templating. A comparison between the s ructural properties, bioactivity and 
biocompatibility of the MPG with a non-porous phosphate-based glass (PG) of analogous 
composition prepared via the same sol-gel synthesis method, but in the absence of a templating 
surfactant is also presented. Results indicate that the MPG has enhanced bioactivity and 
biocompatibility compared to the PG, despite having similar local structure and dissolution 
properties. In contrast to the PG, the MPG shows formation of hydroxyl carbonate apatite 
(HCA) on its surface after 24 hours of immersion in s mulated body fluid. Moreover, MPG 
shows enhanced viability of Saos-2 osteosarcoma cells after 7 days of culturing. This suggests 
that textural properties (porosity and surface area) pl y a crucial role in the kinetics of HCA 
formation and in interaction with cells. Increased efficiency of drug loading and release over 
non-porous PG systems was proved using the antimicrobial tetracycline hydrochloride as a 
drug model. This study represents a significant advance in the field of mesoporous materials 
for drug delivery and bone tissue regeneration as it reports, for the first time, the synthesis, 












Mesoporous glasses for biomedical applications have gained increasing attention in the past 
years.1, 2, 3  Their main characteristics are the presence of extended porosity with pores in the 
size range of 2-50 nm, high surface areas and high pore volumes, which make them ideal 
systems for controlled drug delivery and tissue regeneration applications. Introduction of 
mesoporosity into biomedical glasses i) enhances the interaction between the bioresorbable 
implant and physiological fluids; ii) facilitates the absorption and delivery of therapeutic 
molecules thanks to the open porous structure and homogeneity of pore sizes; iii) guarantees 
multifunctionality, by combining drug delivery and cell stimulation. To date, a significant 
amount of work has been performed on the synthesis of mesoporous silicate-based glasses 
mainly as drug delivery systems4, 5 and for bone tissue regeneration applications.6 It has been 
shown that mesopores can be loaded with high dosages of osteogenic agents and therapeutic 
molecules and that high surface areas enhance the bioactivity of silicate-based glasses.7, 8 
However, to date, there are no examples of mesoporous phosphate-based glasses (MPGs) 
reported in the literature. The synthesis of MPGs has been considered in a recent review as “a 
significantly challenging area for future efforts”.8 This is because the phophate-based glass 
network is more prone to collapsing and crystallisation than the silicate-based glasses under 
the processes required to obtain the mesoporous strcture.8 It has also to be noted that the 
synthesis of mesoporous oxides containing P and Ca is particularly challenging even in 
crystalline form.9 
Phosphate-based glasses (PGs) have recently been prsented as a promising new 
generation of biomaterials as alternatives to the silicate-based glasses. PGs can be defined as 
bioresorbable, as they are able to interact with the physiological fluids producing the desired 
biological response and simultaneously dissolve completely over time being eventually entirely 
replaced by regenerated hard or soft tissue.10, 11   
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In contrast,silicate-based glasses, have a very slow olubility and can only be used to 
manufacture long-term implants, which are susceptible o long-term failure and inflammatory 
reactions.  
Moreover, PGs can be used as controlled local delivery systems for therapeutic 
molecules (e.g. antimicrobial ions and growth factors) that are slowly released as the implant 
degrades. In-situ controlled delivery avoids the need for oral administration and injection, 
improving the quality of life of patients. As the ions released from PGs already exist in the 
body, low toxicity and good biocompatibility is guaranteed.12 
Mesoporous materials are usually prepared in solution via supramolecular chemistry 
using surfactants, which templates the inorganic material. Surfactants spontaneously organise 
(self-assemble) in specific-shaped micelles at the critical micellar concentration, the shape and 
size depending on the specific surfactant used.3 After removal of the surfactant via calcination 
or solvent exchange, pores having the sizes of the mic lles are left in the inorganic material. 
The conventional melt-quench method (MQ) of preparing PGs cannot be used for the synthesis 
of MPGs because it requires melting of oxide powders at temperatures >1100 °C and rapid 
cooling.13 Moreover, this method often leads to non-homogeneous, bulk glasses that cannot be 
used for hosting temperature sensitive molecules.14 
  The sol-gel process (SG), a wet chemical bottom-up technique based on the hydrolysis 
and polycondensation of precursors in solution, has been found to be an excellent alternative 
synthetic route to MQ for the production of PGs.8, 15, 16 In particular, the SG process is ideal 
for the synthesis of mesoporous systems. Surfactant molecules can be easily added using the 
SG method into the precursor solutions and the morphology of pores can be tailored thanks to 
the easily controlled solution-based chemistry. Silicate-based glasses in the SiO2-CaO-Na2O-
P2O5 system synthesised via the SG method have shown to bond to living bone through the 
formation of a hydroxyl carbonate apatite (HCA) layer on their surface.17 It has been shown 
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that the much higher porosity and surface area, as a result of the mesoporous structure, 
enhances the bioactivity of silicate-based sol-gel glasses by accelerating the rate of HCA 
formation and providing an ideal support for cell growth and supply of nutrients.18, 19 Given 
that the composition of PGs is much more similar to the composition of bone and teeth than in 
the case of silicate-based glasses,20 MPGs are expected to induce HCA formation on their 
surface. As observed in silicate-based glasses, introduction of mesoporosity into the PGs is 
expected to accelerate the kinetic deposition process of HCA that favours bone formation.3   
Mesoporous silicate-based glasses have also been used to host, protect and deliver drug 
molecules to the target sites.21 Recent studies have shown high dosages of antimicrobial drug 
molecules can be loaded into mesoporous silicate-bas d glasses to deliver appropriate drug 
concentrations to sites of infection with minimum side effects.21, 22 Introduction of 
mesoporosity into PGs would enhance the potential applications of these materials as 
controlled drug delivery systems, as the majority of drugs used in clinical practise can easily 
be hosted in the mesopores.5 Moreover, similar to the mesoporous silicate-based glasses, the 
surface of MPGs can be functionalised to avoid burst release and facilitate delivery of drug 
molecules to the specific site of action.23, 24  
In the present work, we have synthesised for the first time, a mesoporous calcium phosphate- 
based glass. Bioactivity and biocompatibility were investigated by monitoring HCA formation 
and by seeding Saos-2 cells on the glass surface, respectively. Drug loading efficiency and 
controlled release were investigated by incorporating into the glass tetracycline hydrochloride 
(TCH), a commonly used antibiotic that inhibits protein synthesis.25 Results show that the 
presence of a mesoporous structure clearly enhances bioactivity, biocompatibility, and drug 
loading capability of the phosphate-based glasses. Therefore, MPGs have potential to be used 
as multifunctional bioresorbable systems, in particular for bone regeneration, by combining 
formation of new bone tissue with controlled delivery of therapeutic molecules. 
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2. MATERIALS AND METHODS 
2.1. Materials  
The following chemicals were used without further pu ification: n-butyl phosphate (1:1 molar 
ratio of mono OP(OH)2(OBu) and di-butyl phosphate OP(OH)(OBu)2, Alfa Aesar, 98%), 
calcium methoxyethoxide (Ca-methoxyethoxide, abcr, 20% in methoxyethanol), sodium 
methoxide solution (NaOMe, Aldrich, 30 wt% in methanol), ethanol (EtOH, Fisher, 99%), and 
Pluronic (P123, Mn=5800, Aldrich). 
 
2.2.  Synthesis method 
1.7 g of n-butyl phosphate were added to 5 mL of EtOH in a dried vessel and left under stirring 
for 10 minutes. 3.5 g of Ca-methoxyethoxide and 0.5 g of NaOMe were then added dropwise 
into the mixture while stirring; the solution was kept under stirring for about 1 h. The mixture 
was then divided into two parts: one was used to obain mesoporous phosphate-based glasses 
(MPGs) and the other was used to prepare non-porous pho phate-based glasses (PGs) for 
comparison purposes. In order to prepare MPG, 2.5 gof P123 were dissolved in 5 mL of EtOH 
and 2.5 mL of water, added to the initial mixture and allowed to react for 10 minutes. For the 
preparation of PGs, the initial mixture was used with no addition of P123. PG and MPG 
mixtures were then poured into glass containers and allowed to gel at room temperature. Both 
mixtures turned to gel after about 10 minutes and they were aged for 1 day at room temperature. 
Gels were then dried using a multi-step drying ramp: the temperature was increased from room 
temperature to 40 ˚C and held for 1 day, then to 60 °C and held for 2 days, then to 80 °C and 
held for 2 days and finally to 120 °C and held for 1 day. A calcination step was then performed 
by heating the glasses to 300 °C and holding at this temperature for 1 h to remove the surfactant 
and any remaining solvents from the sample. A heating rate of 1 °C·min-1 was used in all steps 
in order to prevent the collapse of the mesoporous str cture. The obtained glasses were ground 
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at 10 Hz to form microparticles (MM301 milling machine, Retsch GmbH, Hope, UK) and 
microparticles in the size range of 106–200 μm were obtained using test sieves (Endecotts Ltd, 








Wide angle X-ray diffraction (WA-XRD, PANalytical X’Pert, Royston, UK) was performed 
in flat plate geometry using Ni filtered Cu Kα radiation. Scans were collected using a PIXcel-
1D detector with a step size of 0.0525° over the 2θ  range 10-90° with a count time of 12 s per 
step. Low angle X-ray diffraction (LA-XRD, PANalytical X’Pert, Royston, UK) was 
performed using Ni filtered Cu Kα radiation in transmission mode using a focusing mirror on 
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the X-ray incident beam. Scans were collected using a PIXcel-3D detector with a step size of 
0.0525° over the 2θ  range 0.3–6.0° with a count time of 0.017 s per st p. 
Scanning electron microscopy (JSM-7100F, Jeol, Welwyn, UK) was performed at an 
accelerating voltage of 5 kV and working distance of 10.0 mm. The samples were mounted 
onto an aluminium stub using carbon conductive tape. Th  Image-pro plus software (Media 
Cybernetics, USA) was used for image analysis. Energy Dispersive X-ray spectroscopy (EDX) 
was performed using a scanning electron microscope (MagnaRay, ThermoFisher, Hemel 
Hempstead, UK) operating at 20 kV, with spot size 6 and a working distance of 10 mm. 
Solid state 31P MAS NMR spectra (31P MAS-NMR, AVANCE III, Bruker, Coventry, 
UK) were recorded at 161.87 MHz using direct excitation with a 90° pulse and 60 s recycle 
delay at ambient probe temperature (~ 25 ℃). Between 20 and 88 scans were acquired in each 
case. Powder samples were loaded into a 4.0 mm diameter (outside diameter) zirconia rotor 
and spun at 12 kHz. Spectra were referenced to the resonance of the secondary reference 
ammonium dihydrogen phosphate (NH4H2PO4) at 0.9 ppm (relative to 85% H3PO4 solution at 
0 ppm). Spectra were fitted using the Dmfit software package.26 
Fourier Transform Infrared (FT-IR, 2000 series, Perkin Elmer, Seer Green, UK) spectra 
were acquired in attenuated total reflectance mode (Golden Gate, Specac, Orpington, UK) 
using the Timebase software (Perkin Elmer). Spectra were collected at room temperature in 
absorbance mode in the wavenumber range of 600-1500 cm-1. 
Surface area, pore size and pore volume were obtained from N2 adsorption-desorption 
measurements (Gemini V, Micromeritics, Hertfordshire, UK) at 77 K; in particular, the specific 
surface area (SSA) was assessed by using the Brunauer-Emmet-Teller (BET) method, whereas 
the pore size distribution was determined from the desorption branch of the isotherm through 




TCH release was assessed via UV-Vis spectroscopy using a Libra, BioChrom, 
Cambridge, UK in the range 320-450 nm. 
 
2.4. Dissolution studies and pH changes 
Dissolution studies were performed by soaking 10 mg of the MPG and PG powders in 10 mL 
of deionised water for up to 7 days. The experiment was carried out in triplicates (n = 3). The 
resulting suspensions for each time point were centrifuged at 4800 rpm for 10 min to separate 
the undissolved samples from the solution. Concentration of phosphorus, calcium, and sodium 
in the solution were measured by inductively coupled plasma-optical emission spectroscopy 
(ICP-OES, 720ES-Varian, Crawley, UK) calibrated across the predicted concentration range 
using a multi-element standard solution (VWR, Lutterworth, UK). Both samples and standards 
were diluted in 1:1 in 4% HNO3 (Fluka) and analysed with reference to a blank solution (2% 
HNO3) under standard operating conditions (Power: 1350 W; Coolant Flow: 15.0 L·min-1: 
Axillary Flow: 1.0 L·min-1).  
Changes of pH over time were investigated by soaking 10 mg of the MPG and PG 
powders in 10 mL of deionised water (pH = 7.0 ± 0.1) and cell culture medium (pH = 7.8 ± 
0.1). The solutions were stored at 37 °C and the pH was measured for up to 7 days with three 
replicates for each time point using an Orion pH meter (Thermo scientific-Orion star, 
Loughborough, UK).  
 
2.5. In vitro bioactivity and biocompatibility assessment  
In vitro bioactivity was evaluated by immersing 25 mg of MPG and PG powders in 25 mL of 
simulated body fluid (SBF), a solution with ion cone trations very similar to human blood 
plasma,27 stored in an incubator  at 37 °C while shaking at 100 rpm for 24 h. The samples were 
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then washed with water and ethanol and finally dried at 60 °C for 6 h before WA-XRD 
characterisation and observation of their surfaces with SEM. 
In vitro biocompatibility was assessed by seeding Saos-2 cells (HTB85, ATCC, UK) 
on MPG and PG powders. Saos-2 cells were chosen as representative of osteoblast behaviour 
and cultured in medium (McCoy’s 5a, ATCC, UK) with 15% fetal bovine serum (FBS, Gibco, 
Invitrogen, Loughborough, UK) and 1% Antibiotic-Antimycotic (Thermo Scientific, 
Loughborough, UK) in a humidified incubator at 37 °C and 5% CO2. On reaching 90% 
confluency, cells were passaged and used for cytocompatibility analysis. To facilitate the 
attachment of the cells on to the MPG and PG powders for SEM imaging, polycarbonate cell 
culture inserts with 0.4 µm pore size (Millipore, Merck, UK) were used. 10 mg of MPG and 
PG powders were placed on the inserts and incubated with the medium overnight. 
Approximately 1.2 × 104 cells were placed in each insert and cultured for 7 days with cell 
viability assessment during the culture period. Cells only on inserts were used as a control for 
comparison purposes. 
SEM was used to visualise cell attachment and growth on MPG and PG surfaces. At 
the end of day 7, cells were fixed with 3% glutaraldehyde (Sigma-Aldrich) followed by 
dehydration using graded ethanol. Samples were then air dried, gold sputter coated and 
visualised using SEM. To visualise the nucleus and actin filaments, cells were fixed using 4% 
paraformaldehyde and stained with DAPI- Phalloidin at the end of day 7. Samples were 
incubated for 20 min at room temperature in staining solution containing 2.5 µL of DAPI (1 
mg·mL-1 stock solution), 4 µL of Phalloidin (200 U·mL-1 stock concentration, Alexa Fluor 488, 
Phalloidin, Life Technologies) and 20 µL of Triton X per mL of PBS. Cells were then 
visualised using a cell image multi-mode reader (Cytation-5, BioTek, Swindon, UK). 
 
2.6. Drug loading and in vitro drug release study 
10 
 
To assess the intake of drugs for controlled delivery applications of MPG and PG, 
tetracycline hydrochloride (TCH) was added to the samples via impregnation. 5 mg of MPG 
and PG powders were soaked in 5 mL TCH solution prepared by adding 5 mg TCH in 5 mL of 
ethanol. The mixtures were stirred for 60 min at room temperature and then centrifuged at 4800 
rpm for 5 min to separate the impregnated glass particles from the solutions. The glasses 
impregnated with TCH were then washed once with ethanol and centrifuged to remove the 
excess of unloaded TCH. The glasses were then driedov rnight at room temperature. TCH 
release was assessed by adding 5 mL of deionised water to the samples, keeping them in an 
incubator at 37 °C under shaking at 100 rpm and colle ting the solution at different time points 
up to 24 h. Three replicates for each time point were measured. 
TCH release was assessed via UV-Vis spectroscopy using a Libra, BioChrom, Cambridge, 
UK in the range 320-450 nm. 
 
3. RESULTS AND DISCUSSION 
Chemical analysis of MPG and PG samples was carried out using SEM equipped with an EDX 
detector in order to determine their exact compositions. Table 1 reports compositions 
expressed in terms of oxide mol %; elemental composition  in terms of weight % and mol % 
along with the EDX spectra are reported in Table S1 and Figure S1, respectively. As expected, 
MPG and PG samples have very similar compositions (P2O5 ∼ 45-46 mol %, CaO ∼ 35-36 mol 
% and Na2O ∼ 19 mol %). The oxide content was chosen on the basis of previous studies on 
MQ and SG phosphate-based glasses. Glasses with P2O5 content in the range 40-50 mol % and 
CaO content in the range 20-40 mol % have been shown t  have good bioactivity and 
biocompatibility.15, 28 
 




Oxides (mol %) 
P2O5 CaO Na2O 
MPG 45.0 (±1.2) 36.0 (±0.9) 19.0 (±0.5) 
PG 46.0 (±0.9) 35.0 (±0.7) 19.0 (±0.6) 
 
 
In order to assess the amorphous nature of synthesised samples, WA-XRD was 
performed. The WA-XRD patterns, reported in F gure 2A, do not show any Bragg peaks, with 
only broad halo centred at around 2θ ~ 28°, clearly indicating that both samples are fully 
amorphous. Despite similar content and WA-XRD patterns, MPG and PG are expected to show 
very different textural properties given that only MPG was synthesised using the templating 
agent P123. This was confirmed by N2 adsorption and desorption analysis at 77 K (Figure 2B). 
MPG shows an adsorption-desorption isotherm that can be classified as type IV, characteristic 
of mesoporous solids, whereas PG, which does not show an adsorption-desorption isotherm, is 
clearly non-porous. The shape of the MPG hysteresis loop can be classified as type H1, which 
is typical of cylindrical pores arranged in a hexagonal manner open at both ends.29 The presence 
of cylindrical pores is in agreement with the type of surfactant used (P123) which is known to 
form cylindrical micelles, which aggregate forming two dimensional hexagonal arrangements,3 
leaving hexagonal arrays of unidirectional cylindrical pores after calcination. MPG presents a 
narrow, single modal pore size distribution centred at around 12 nm (inset of Figure 2B). The 
surface area calculated using the BET model is 124 m2·g-1 and the pore volume is 0.28 cm3·g-
1. Despite the surface area being lower than typical mesoporous silicate-based glasses, the result 
is remarkable as it is the first example ever reported of a mesoporous calcium phosphate-based 
glass, which are known to have a much weaker network structure than silicate-based ones.8 
The size of the mesopores is also ideal as 12 nm pores can easily accommodate the majority of 
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drug molecules of interest in clinical applications.7 Further evidence of the presence of 
mesopores in MPG was given by SEM analysis. The SEM image reported in Figure 2C clearly 
shows a highly porous structure with a pore size range of 10-20 nm, in good agreement with 
the pore size distribution obtained via N2 adsorption at 77 K. A wall thickness of 4-5 nm was 
estimated from SEM images which is in agreement with typical values found in mesoporous 
silicate-based glasses prepared using P123 as a surfactant.30  Moreover, by looking carefully at 
the local arrangement of pores, a hexagonal arrangement of mesopores can be seen (zoomed 
area in Figure 2C), suggesting a certain local order of mesopores. This is in agreement with 
the type H1 hysteresis loop observed in the N2 adsorption-desorption isotherm. The SEM 
images of PG, reported in Figure S2, do not show any porosity, as expected. 
In order to further investigate the arrangement of mesopores in MPG, LA-XRD was 
performed on MPG and also on PG for comparison (Figure 2D). MPG shows a strong 
reflection at 2θ = 0.8° and a broader reflection at 2θ = 2.6°, consistent with a degree of order 
in the arrangement of pores. These reflections can be assigned to the (100) and (200) sets of 
planes, respectively, in the 2D hexagonal mesoporous p rous structure.9, 31 As expected for a 





Figure 2.  Characterisation of MPG and PG samples: (A) WA-XRD patterns, (B) N2 adsorption 
and desorption isotherms; inset: BJH pore size distribution, (C) SEM image of MPG (a); detail 
of blue squared area (b), and (D) LA-XRD patterns. 
 
The textural properties of MPG and PG are clearly very different as expected. It is 
therefore interesting to investigate if the different morphologies affect the structural properties, 
in particular the way the phosphate chains are linked. 31P MAS NMR is a very powerful tool 
for the investigation of the local environment around phosphorus and the connectivity of the 
phosphate units. The 31P MAS NMR spectra of both MPG and PG samples are presented in 
Figure 3A. Resonances are assigned to Qn phosphate species, where n represents the number 
of bridging oxygens between phosphate units. Both spectra show a main resonance at about -6 
ppm ascribed to Q1 groups with a relative intensity in the range 68-73% and a less intense 
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resonance (27-32%) at about -23 ppm ascribed to Q2 groups (Table S2). Results are in 
agreement with previous studies on non-porous SG phosphate-based glasses of similar 
composition that show a structure dominated by Q1 groups with a smaller percentage of Q2.12 
A confirmation of the fact that the textural properti s do not affect the structure of the 
phosphate chains is given by FT-IR spectroscopy. As shown in Figure 3B, the FT-IR spectra 
of MPG and PG, measured in the range 600-1500 cm-1 are very similar. The band at ∼1100 cm-
1 and the shoulder at ∼1235 cm-1 can be assigned to the asymmetric stretching υas (PO3)-2 and 
υas (PO2) modes, respectively, related to Q1 and Q2 phosphate units, respectively. The band at 
∼900 cm-1 and the less intense band at ∼730 cm-1 can be assigned to the asymmetrical stretching 





Figure 3. (A) 31P MAS NMR and (B) FT-IR spectra of MPG and PG samples.  
 
As phosphate-based glasses have great potential as bioresorbable materials, it is 
important to assess their potential as controlled delivery systems. In particular, it is interesting 




different textural properties, but similar structure. The release of phosphorus, calcium, and 
sodium in deionised water at different time points up to 7 days was measured via ICP-OES and 
data presented in Figure 4A, 4B and 4C, respectively. Results show that release profiles do 
not change significantly with change in porosity, esp cially during the first 8 h. In particular, 
P release is identical in MPG and PG samples for the first 8 h, Ca release is identical for the 
first 12 h and Na release is identical for the first 72 h.  Dissolution trends that follow the initial 
overlapping release are similar for MPG and PG system . However, a slightly higher amount 
of P, Ca and Na is released over time by the MPGs system. 
Along with the dissolution products, pH change was also monitored over time. pH 
monitoring is important in order to evaluate the potential application of MPGs as biomaterials. 
pH change was monitored in both deionised water and cell culture medium over a period of 7 
days (Figure 4D).  pH changes of MPG and PG samples over time follow a similar trend, as 
observed for the release of P, Ca and Na. However, th  pH values for PG are slightly higher 
than for MPG. The pH values measured in deionised water remain relatively neutral, dropping 
from 7.0 to ∼6.2 after 8 h, increasing slightly up to 24 h and then remaining stable up to 7 days 
at around 6.4. The pH values measured in cell culture medium drop from 7.8 to 7.4 after 8 h, 
increasing slightly up to 24 h and then remaining stable up to 7 days around 7.6. The initial pH 
reduction can be ascribed to the dissociation of phs ate anions released with formation of 
phosphoric acid.34 The slight increase in pH following that can be relat d to the presence of 








Figure 4. Release of (A) phosphorus, (B) calcium, and (C) sodium in deionised water 
measured by ICP-OES and (D) pH change in deionised water and cell culture medium 
as a function of time for MPG and PG samples. 
 
Dissolution studies have shown that P, Ca and Na can be released in a controlled way. 
The capability of releasing phosphate and calcium ions has been linked to the bioactivity of 
glasses, in particular with the formation of HCA on the glass surface when in contact with the 
damaged bone site.35 As HCA is a naturally occurring mineral present in bones and teeth, the 
formation of HCA can be used as indication of the bioactivity (osseointegration) of MPGs.36 
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Previous studies have shown that mesoporous silicate-based glasses have superior in vitro 
bioactivity and in vivo osteogenic properties compared to the corresponding non-porous 
systems.37 However, to the knowledge of the authors, no work has been done on bioactivity of 
phosphate-based glasses synthesised via sol-gel rout . It is therefore interesting to investigate 
the capability of MPG and PG in forming HCA on their surface. The in vitro bioactivity of the 
MPG and PG samples was investigated by immersing the lasses in SBF for 24 h. As shown 
in Figure 5A, the WA-XRD pattern of MPG after immersion in SBF clearly indicates the 
precipitation of a crystalline phase that can be ascribed to HCA (ICDD card No. 24-0033). On 
the other hand, no crystallisation is observed on the surface of PG. XRD results are confirmed 
by FT-IR analysis, performed before and after immersion of MPG in SBF (Figure S3). After 
immersion, two bands at 1037 cm-1 and 962 cm-1 can be observed, corresponding to the 
antisymmetric and symmetric P-O stretching mode, respectively. These band have been 
ascribed to nanocrystalline HA.38 
Results are confirmed by SEM analysis that clearly shows formation of HCA 






Figure 5. (A) XRD patterns of MPG and PG; SEM images of (B) MPG and (C) PG after 
immersion in SBF for 24 h at 37 °C. The scale bar is 1 µm.  
It is not excluded that HCA could also form inside th mesopores given that the surface area 
of MPG after immersion in SBF is lower than before immersion (63 m2·g). Also, the 
absorption-desorption hysteresis loop of has changed, as reported in Figure S4.  
It is interesting to note that despite the release of P, Ca and Na being quite similar in 
MPG and PG (as shown in the dissolution studies), n vitro bioactivity is greater in MPG (as 
demonstrated by HCA formation on MPG only). Moreover, the composition of MPG and PG 
is identical. Therefore, these results indicate that higher bioactivity can be achieved solely by 
changing the textural properties of the system. In particular, results clearly show that the 
mesoporosity increases the rate of HCA formation on the surface of MPG and likely also inside 
the mesopores”. This suggests that high surface area and high porosity allow a better diffusion 
of physiological fluids into the glass, which could be responsible for the enhancement of the 
kinetic of processes at the interfaces.3 Difference in bioactivity cannot be ascribed to a ch nge 
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in the local structure, given that 31P MAS NMR has shown the presence of the same phosphate 
units (Q1 and Q2) in similar amounts and FT-IR spectra are also very similar.  
Given the very promising results on osseointegration of MPG, biocompatibility was 
assessed by evaluating viability and attachment of Saos-2 osteosarcoma cells cultured on its 
surfaces. These cells were selected because they possess several osteoblastic features and can 
therefore be used to mimic the osteoblast response to the glasses.39 Saos-2 cells were also 
cultured on PG for comparison purposes. The control consisted of Saos-2 cells seeded directly 
on a cell culture support. 
Cell viability was quantitatively assessed using the Alamar Blue fluorescence assay 
after 1, 3, 5, and 7 days. The graph shown in Figure 6A represents the change in fluorescence 
of Alamar Blue dye as a direct indicator of cellular metabolic activity which is directly linked 
to the number of cells. Cell growth does not change si nificantly in the first 3 days for PG; 
however, MPG shows a slight increase after day 3. At day 5 and 7, both MPG and PG show an 
increase cell proliferation. However, MPG clearly shows higher cell proliferation than PG.  
Cell attachment was assessed via SEM and DAPI-Phalloidin staining. Figure 6B shows 
SEM images of Saos-2 cells well attached and widely spread on the surface of MPG and PG 
over a 7-day period. SEM results were confirmed by qualitative analysis based on DAPI- 
Phalloidin staining (Figure 6C). Cell nuclei (blue) and filaments (green) show that cells are 




Figure 6. (A) Saos-2 cell viability measurement using the Alamar Blue fluorescence assay 
after 1, 3, 5 and 7 days; error bars are SD (n = 3); (B) SEM images showing Saos-2 cells 
attachment after 7 days at two different magnifications; (C) DAPI- Phalloidin staining after 7 




Mesoporous silicate-based glasses have been shown to be excellent drug loading and 
release systems thank to the extended porosity.5, 21 Therefore, MPGs are also expected to show 
enhanced drug intake and controlled release. This wa investigated using tetracycline 
hydrochloride (TCH) as a model antibiotic, often administrated to patients after surgery to 
avoid bacterial infections. MPG and PG samples were loaded with TCH by impregnation. The 
release of TCH in deionised water was then studied over a period of 24 h (Figure 7). The 
loaded MPG shows a sharp TCH release in the first hour (100 µg) followed by a sustained 
release reaching to 130 µg after 24 h. However, loaded PG shows a total releas  of about 30 
µg within the first 30 min. Given that the dissolution properties of the MPG and PG samples 
in deionised water are very similar, the different TCH release behaviour can be ascribed to a 
different TCH loading and texture. In particular, the high porosity and surface area of the MPG 
system allows for a significantly higher drug loading than the non-porous PG, which explains 
the higher release of TCH from loaded MPG in comparison to loaded PG.  
The higher loading of TCH in MPG compared to PG wasconfirmed by measuring the 
UV-Vis spectra of TCH remaining in the supernatant solution after impregnation. Figure S5 
shows that the amount of TCH remaining in the supernatant solution is higher after 
impregnation of PG than MPG, indicating a lower amount of TCH absorbed in PG. This is in 
agreement with previous results reported in literature on mesoporous silicate-based glasses 
which have been shown to have much higher loading efficiency than the non-porous ones.40  
Moreover, loaded MPG shows a more sustained release during the 24 h of the study. 
This could be explained considering that TCH molecul s are initially incorporated into the 
mesopores and then slowly released.41 It is interesting to note that differently from TCH 
release, ion release does not change significantly wi h porosity. This can be explained by the 
fact that ions are added into the phosphate network before formation of the mesoporous 
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structure whereas TCH has been added to the glass vi  impregnation of the mesoporous 
structure.   
 
 
Figure 7. Release profiles of TCH as a function of time from loaded MPG and PG samples. 
 
4. CONCLUSIONS 
This study presents the first example of a mesoporous calcium phosphate-based glass ever 
reported and investigates its potential applications as multifunctional material for controlled 
drug delivery and bone tissue regeneration.  MPG, prepared using a combination of sol-gel 
chemistry and supramolecular templating, has a surface area of 124 m2·g-1, an average pore 
size of 12 nm, and pore volume of 0.28 cm3·g-1. 31P MAS-NMR results show that it is mainly 
formed by Q1 groups (68%) and Q2 groups (32%). Dissolution studies have shown gradual 
release of P, Ca and Na over time which makes it excellent candidate as controlled delivery 
system. Moreover, pH remains near neutral upon dissolution in cell medium. A comparison 
between MPG and non-porous glass of the same composition (PG) shows that they have similar 
structure and dissolution properties. However, they show very different in vitro bioactivity, 
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biocompatibility and drug loading/release properties because of their different textural 
properties. Presence of mesoporosity has shown enhancement of the kinetics of HCA 
formation, which appears on the surface of MPG within e first 24 h of immersion in SBF. 
Cytotoxicity studies indicate that mesoporosity also enhances Saos-2 osteosarcoma cells 
attachment and proliferation on the surfaces of the glasses. Studies on incorporation and release 
of the antibiotic TCH into MPG have shown that the extended porosity and high surface area 
allow for a higher loading and more controlled releas  over time compared to the analogous 
non-porous system PG. The novel synthetic route present d in this work opens new horizons 
in designing a new generation of non- siliceous, mesoporous glasses with great potential in 
tissue engineering and drug delivery systems. 
 
SUPPORTING INFORMATION AVAILABLE 
The following files are available free of charge: dtails of elemental compositions measured 
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Samples Element weight % Element mol %  
  P Ca Na O P Ca Na O 
PG 29.8 14.7 9.1 46.4 20.8 7.9 8.6 62.7 
MPG 29.1 15.0 8.8 47.1 20.2 8.1 8.3 63.4 














Table S2. 31P MAS NMR spectral parameters (chemical shift, δiso) and relative intensity (I %) 




 δiso (ppm) I % δiso (ppm) I % 
PG - 6.1 73 - 23.2 27 
MPG - 6.2 68 - 23.0 32 
 
 
Figure S1. EDX spectra of (A) PG and (B) MPG  
